FR-900098, an antimalarial development candidate that inhibits the non-mevalonate isoprenoid biosynthesis pathway, shows no evidence of acute toxicity and genotoxicity

References

• Wiesner J, Reichenberg A, Heinrich S, Schlitzer M, Jomaa H. The plastid-like organelle of apicomplexan parasites as drug target. Curr Pharm Des 2008; 14:855-71; PMID:18473835; http://dx.doi.org/10.2174/138161208784041105
   PubMed Web of Science ®Google Scholar
• Kuzuyama T, Shizimu T, Takahashi S, Seto H. Fosmidomycin, a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway of isoprenoidbiosynthesis. Tetrahedron Lett 1998; 39:7913-6; http://dx.doi.org/10.1016/S0040-4039(98)01755-9
   Web of Science ®Google Scholar
• Zeidler J, Schwender J, Müller C, Wiesner J, Weidemeyer C, Beck E, Jomaa H, Lichtenthaler HK. Inhibition of the non-mevalonate 1-deoxy-D-xylulose-5-phosphate pathway of plant isoprenoid biosynthesis by fosmidomycin. Z Naturforsch C 1998; 53:980-6
   Web of Science ®Google Scholar
• Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, Hintz M, Türbachova I, Eberl E, Zeidler J, Lichtenthaler HK, Soldati D, Beck E. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 1999; 285:1573-6; PMID:10477522; http://dx.doi.org/10.1126/science.285.5433.1573
   PubMed Web of Science ®Google Scholar
• Tahar R, Basco LK. 2007. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-d-xylulose 5-phosphate reductoisomerase. Am J Trop Med Hyg 2007; 77:214-20; PMID:17690389
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Wiesner J, Weidemeyer C, Dreiseidler E, Sanderbrand S, Altincicek B, Beck E, Schlitzer M, Jomaa H. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Bioorg Med Chem Lett 2001; 11:833-5; PMID:11277531; http://dx.doi.org/10.1016/S0960-894X(01)00075-0
   PubMed Web of Science ®Google Scholar
• Giessmann D, Heidler P, Haemers T, Van Calenbergh S, Reichenberg A, Jomaa H, Weidemeye C, Sanderbrand S, Wiesner J, Link A. Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-d-xylulose-5-phosphate reductoisomerase inhibitors. Chem Biodivers 2008; 5:643-56; PMID:18421757; http://dx.doi.org/10.1002/cbdv.200890060
   PubMedGoogle Scholar
• Umeda T, Tanaka N, Kusakabe Y, Nakanishi M, Kitade Y, Nakamura KT. Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum. Sci Rep 2011; 1:9; PMID:22355528; http://dx.doi.org/10.1038/srep00009
   PubMed Web of Science ®Google Scholar
• Horbach S, Sahm H, Welle R. Isoprenoid biosynthesis in bacteria: two different pathways? FEMS Microbiol Lett 1993; 111:135-40; PMID:8405922; http://dx.doi.org/10.1111/j.1574-6968.1993.tb06375.x
   PubMed Web of Science ®Google Scholar
• Sprenger GA, Schorken U, Wiegert T, Grolle S, de Graaf AA, Taylor SV, Begley TP, Bringer-Meyer S, Sahm H. Identification of a thiamin-dependent synthase in Escherichia coli required for the formation of the 1-deoxy-d-xylulose 5-phosphate precursor to isoprenoids, thiamin, and pyridoxol. Proc Natl Acad Sci USA 1997; 94:12857-62; PMID:9371765; http://dx.doi.org/10.1073/pnas.94.24.12857
   PubMedGoogle Scholar
• Okuhara M, Kuroda Y, Goto T, Okamoto M, Terano H, Kohsaka M, Aoki H, Imanaka H. Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization. J Antibiot (Tokyo) 1980; 33:13-7; PMID:6768704; http://dx.doi.org/10.7164/antibiotics.33.13
   PubMed Web of Science ®Google Scholar
• Okuhara M, Kuroda Y, Goto T, Okamoto M, Terano H, Kohsaka M, Aoki H, Imanaka H. Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289. J Antibiot (Tokyo) 1980; 33:24-8; PMID:6768705; http://dx.doi.org/10.7164/antibiotics.33.24
   PubMed Web of Science ®Google Scholar
• Mine Y, Kamimura T, Nonoyama S, Nishida M, Goto S, Kuwahara S. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic. J Antibiot (Tokyo) 1980; 33:36-43; PMID:7372548; http://dx.doi.org/10.7164/antibiotics.33.36
   PubMed Web of Science ®Google Scholar
• Kuemmerle HP, Murakawa T, Soneoka K, Konishi T. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies. Int J Clin Pharmacol Ther Toxicol 1985; 23:515-20; PMID:4066075
   PubMed Web of Science ®Google Scholar
• Kuemmerle HP, Murakawa T, Sakamoto H, Sato N, Konishi T, De Santis F. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies. Int J Clin Pharmacol Ther Toxicol 1985; 23:521-528; PMID:4066076
   PubMed Web of Science ®Google Scholar
• Missinou MA, Borrmann S, Schindler A, Issifou S, Adegnika AA, Matsiegui PB, Binder R, Lell B, Wiesner J, Baranek T, Jomaa H, Kremsner PG. Fosmidomycin for malaria. Lancet 2002; 360:1941-2; PMID:12493263; http://dx.doi.org/10.1016/S0140-6736(02)11860-5
   PubMed Web of Science ®Google Scholar
• Lell B, Ruangweerayut R, Wiesner J, Missinou MA, Schindler A, Baranek T, Hintz M, Hutchinson D, Jomaa H, Kremsner PG. Fosmidomycin, a novel chemotherapeutic agent for malaria. Antimicrob Agents Chemother 2003; 47:735-8; PMID:12543685; http://dx.doi.org/10.1128/AAC.47.2.735-738.2003
   PubMed Web of Science ®Google Scholar
• Lell B, Kremsner PG. Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother 20002; 46:2315-20; PMID:12121898; http://dx.doi.org/10.1128/AAC.46.8.2315-2320.2002
   PubMed Web of Science ®Google Scholar
• Borrmann S, Issifou S, Esser G, Adegnik AA, Ramharter M, Matsiegui PB, Oyakhirome S, Mawili-Mboumba PD, Missinou MA, Kun JF, et al. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria. J Infect Dis 2004; 190:1534-40; PMID:15478056; http://dx.doi.org/10.1086/424603
   PubMed Web of Science ®Google Scholar
• Borrmann S, Lundgren I, Oyakhirome S, Impouma B, Matsiegui PB, Adegnika A, Issifou S, Kun JF, Hutchinson D, Wiesner J, et al. Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria. Antimicrob Agents Chemother 2006; 50:2713-18; PMID:16870763; http://dx.doi.org/10.1128/AAC.00392-06
   PubMed Web of Science ®Google Scholar
• Oyakhirome S, Issifou S, Pongratz P, Barondi F, Ramharter M, Kun JF, Missinou, Lell B, Kremsner PG. Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother 2007; 51:1869-1871; PMID:17325227; http://dx.doi.org/10.1128/AAC.01448-06
   PubMed Web of Science ®Google Scholar
• Ruangweerayut R, Looareesuwan S, Hutchinson D, Chauemung A, Banmairuroi V, Na-Bangchang K. Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria. Malar J 2008; 7:225; PMID:18973702; http://dx.doi.org/10.1186/1475-2875-7-225
   PubMed Web of Science ®Google Scholar
• Borrmann S, Adegnika AA, Matsiegui PB, Issifou S, Schindler A, Mawili-Mboumba DP, Baranek T, Wiesner J, Jomaa H, Kremsner PG. Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. J Infect Dis 2004; 189:901-8; PMID:14976608; http://dx.doi.org/10.1086/381785
   PubMed Web of Science ®Google Scholar
• Na-Bangchang K, Ruengweerayut R, Karbwang J, Chauemung A, Hutchinson D. Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria. Malar J 2007; 6:70; PMID:17531088; http://dx.doi.org/10.1186/1475-2875-6-70
   PubMed Web of Science ®Google Scholar
• Lanaspa M, Moraleda C, Machevo S, González R, Serrano B, Macete E, Cisteró P, Mayor A, Hutchinson D, Kremsner PG, Alonso P, Menéndez C, Bassat Q. Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother 2012; 56:2923-8; PMID:22430959; http://dx.doi.org/10.1128/AAC.00018-12
   PubMed Web of Science ®Google Scholar
• Fernandes JF, Lell B, Agnandji ST, Obiang RM, Bassat Q, Kremsner PG, Mordmüller B, Grobusch MP. Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials. Future Microbiol 2015; 10:1375-90; PMID:26228767; http://dx.doi.org/10.2217/FMB.15.60
   PubMed Web of Science ®Google Scholar
• Ames BN, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 1975; 31:347-64; PMID:768755; http://dx.doi.org/10.1016/0165-1161(75)90046-1
   PubMed Web of Science ®Google Scholar
• Honma M, Hayashi M, Shimada H, Tanaka N, Wakuri S, Awogi T, Yamamoto KI, Kodani NU, Nishi Y, Nakadate M, Sofuni T. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis 1999; 14:5-22; PMID:10474816; http://dx.doi.org/10.1093/mutage/14.1.5
   PubMed Web of Science ®Google Scholar
• Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Delongchamp R, Durward R, Fellows M, et al. Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing–Aberdeen, Scotland, 2003–Assay acceptance criteria, positive controls, and data evaluation. Environ Mol Mutagen 2006; 47(1):1-5; PMID:15991242; http://dx.doi.org/10.1002/em.20159
   PubMed Web of Science ®Google Scholar
• Moore MM, Honma M, Clements J, Bolcsfoldi G, Cifone M, Delongchamp R, Fellows M, Gollapudi B, Jenkinson P, Kirby P, et al. Mouse lymphoma assay workgroup. 2003. mouse lymphoma thymidine kinase gene mutation assay: international workshop on genotoxicity tests workgroup report–plymouth, UK 2002. Mutat Res 2003; 540:127-40; PMID:14550497; http://dx.doi.org/10.1016/j.mrgentox.2003.07.003
   PubMed Web of Science ®Google Scholar
• Storer RD, Kraynak AR, McKelvey TW, Elia MC, Goodrow TL, DeLuca JG. The mouse lymphoma L5178Y Tk+/− cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat Res 1997; 373(2):157-65; PMID:9042396; http://dx.doi.org/10.1016/S0027-5107(96)00227-8
   PubMed Web of Science ®Google Scholar
• Hayashi M, Tice RR, MacGregor JT, Anderson D, Blakey DH, Kirsch-Volders M, Oleson FB Jr, Pacchierotti F, Romagna F, Shimada H, et al. In vivo rodent erythrocyte micronucleus assay. Mutat Res 1994; 312:293-304; PMID:7514741; http://dx.doi.org/10.1016/0165-1161(94)90039-6
   PubMed Web of Science ®Google Scholar
• Baumeister S, Wiesner J, Reichenberg A, Hintz M, Bietz S, Harb OS, Roos DS, Kordes M, Friesen J, Matuschewski K, et al. Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways. PLoS One 2011; 6:e19334; PMID:21573242; http://dx.doi.org/10.1371/journal.pone.0019334
   PubMedGoogle Scholar
• Kamiya T, Hashimoto M, Hemmi K, Takeno H. Hydroxyaminohydrocarbon-phosphonic acids. Fujisawa Pharmaceutical Co. Ltd. U.S. Patent Application No. 4,206,156, 3 June 1980.
   Google Scholar
• Öhler E, Kanzler S. Regioselective palladium(0) catalyzed amination of carbonates of allylic a-hydroxyphosphonates with hydroxylamine derivatives: A convenient route to phosphonic acids related to the antibiotic fosmidomycin. Synthesis 1995;539-43
   Web of Science ®Google Scholar
• Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res 1983; 113:173-215; PMID:6341825; http://dx.doi.org/10.1016/0165-1161(83)90010-9
   PubMed Web of Science ®Google Scholar
• Clive D, Spector JF. Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutat Res 1975; 31:17-29; PMID:1093012; http://dx.doi.org/10.1016/0165-1161(75)90059-X
   PubMed Web of Science ®Google Scholar
• Schmid W. The micronucleus test for cytogenetic analysis. In Chemical mutagens, principle and methods for their detection A. Hollaender (ed.), vol. 1. Plenum Press: New York, NY. 1976; pp. 31-53.
   Google Scholar
• Heddle JA, Stuart E, Salamone MF. 1984. The bone marrow micronucleus test, In G. J. Kilbey, et al. (ed.) Handbook of mutagenicity test procedures, 2nd ed. Elsevier: Amsterdam. p. 441-457.
   Google Scholar
• Mavournin KH, Blakey DH, Cimino MC, Salamone MF, Heddle JA. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. environmental protection agency gene-tox program. Mutat Res 1990; 239:29-80; PMID:2195332; http://dx.doi.org/10.1016/0165-1110(90)90030-F
   PubMed Web of Science ®Google Scholar